NASDAQ | ETF
Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies in the healthcare sector.
It invests significantly in early-stage companies within the healthcare equipment and supplies, pharmaceuticals, biotechnology, and life sciences industries that are not yet consistently profitable.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 4.71% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 3.33% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 3.03% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 2.66% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 2.66% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.47% |
| BIO | Bio-Rad Laboratories Inc | Healthcare | Medical Devices | 2.38% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 2.19% |
| CTLT | Catalent Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.15% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 2.08% |
| MAAC | Montes Archimedes Acquisition Corp | Financial Services | Shell Companies | 1.75% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 1.71% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 1.66% |
| CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 1.63% |
| SMMT | Summit Therapeutics PLC | Healthcare | Biotechnology | 1.56% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 1.52% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 1.51% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 1.44% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.34% |
| ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 1.29% |